Literature DB >> 2215182

Anti-adhesive activity of human casein against Streptococcus pneumoniae and Haemophilus influenzae.

G Aniansson1, B Andersson, R Lindstedt, C Svanborg.   

Abstract

The casein fraction of human milk was found to inhibit the attachment of Streptococcus pneumoniae and Haemophilus influenzae human respiratory tract epithelial cells. The inhibitory activity for S. pneumoniae remained after heat and trypsin treatment of the casein and was found in oligosaccharides released from casein. kappa-Casein, which is the most highly glycosylated casein component, inhibited pneumococcal attachment at concentrations similar to the whole casein fraction. The results are consistent with the known recognition of GlcNAc beta 1-3Gal by S. pneumoniae, since human milk and bovine colostrum, which contain GlcNAc, inhibited attachment, but mature bovine milk lacking GlcNAc did not. The effect on H. influenzae was similar to that on S. pneumoniae in that the attachment was inhibited by human casein and bovine colostrum, but not by either mature bovine milk or by the bovine casein fraction. The kappa-casein component of human milk was a less efficient inhibitor of H. influenzae attachment than the whole casein fraction and the free oligosaccharides were inactive. This anti-microbial effect of human casein represents a new mechanism for the protection by breast-milk against respiratory tract infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2215182     DOI: 10.1016/0882-4010(90)90090-d

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  12 in total

1.  Identification of lipopolysaccharide-binding proteins in porcine milk.

Authors:  Farshid Shahriar; John R Gordon; Elemir Simko
Journal:  Can J Vet Res       Date:  2006-10       Impact factor: 1.310

2.  Blocking of fimbria-mediated adherence of Haemophilus influenzae by sialyl gangliosides.

Authors:  L van Alphen; L Geelen-van den Broek; L Blaas; M van Ham; J Dankert
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

Review 3.  The impact of the milk glycobiome on the neonate gut microbiota.

Authors:  Alline R Pacheco; Daniela Barile; Mark A Underwood; David A Mills
Journal:  Annu Rev Anim Biosci       Date:  2014-11-05       Impact factor: 8.923

Review 4.  Oligosaccharides and glycoconjugates in human milk: their role in host defense.

Authors:  D S Newburg
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

5.  Extensive in vivo human milk peptidomics reveals specific proteolysis yielding protective antimicrobial peptides.

Authors:  David C Dallas; Andres Guerrero; Nora Khaldi; Patricia A Castillo; William F Martin; Jennifer T Smilowitz; Charles L Bevins; Daniela Barile; J Bruce German; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2013-04-24       Impact factor: 4.466

6.  Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species.

Authors:  F Minervini; F Algaron; C G Rizzello; P F Fox; V Monnet; M Gobbetti
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792

7.  Milk Peptidomics to Identify Functional Peptides and for Quality Control of Dairy Products.

Authors:  David Dallas; Søren Drud Nielsen
Journal:  Methods Mol Biol       Date:  2018

8.  Polyphosphoinositides suppress the adhesion of Haemophilus influenzae to pharyngeal cells.

Authors:  Jim-Wen R Liu; Steve N Anderson; Jonathan A Meulbroek; Shie-Ming Hwang; Pradip Mukerji; Yung-Sheng Huang
Journal:  Lipids Health Dis       Date:  2004-09-03       Impact factor: 3.876

9.  Monotreme lactation protein is highly expressed in monotreme milk and provides antimicrobial protection.

Authors:  Ashwantha Kumar Enjapoori; Tom R Grant; Stewart C Nicol; Christophe M Lefèvre; Kevin R Nicholas; Julie A Sharp
Journal:  Genome Biol Evol       Date:  2014-09-22       Impact factor: 3.416

Review 10.  Breast milk and Group B streptococcal infection: vector of transmission or vehicle for protection?

Authors:  Kirsty Le Doare; Beate Kampmann
Journal:  Vaccine       Date:  2014-04-13       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.